Spatial Signatures Transform Treatment of Lung Cancer
Kilder
- Nature: Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer - Nature
- Statnews: Sarepta to seek approval for gene therapy in rare form of muscular dystrophy - statnews.com
- Fiercebiotech: BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence - Fierce Biotech
- Fiercebiotech: Novo shutters cell therapy unit, ending work on potential Type 1 diabetes 'cure' - Fierce Biotech
- Nature: Cancer cachexia contender enters first pivotal trial - Nature
- Biospace: Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress - BioSpace
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.